210 related articles for article (PubMed ID: 30790291)
1. Comparison of combination l-asparaginase plus CHOP or modified MOPP treatment protocols in dogs with multi-centric T-cell or hypercalcaemic lymphoma.
Angelo G; Cronin K; Keys D
J Small Anim Pract; 2019 Jul; 60(7):430-437. PubMed ID: 30790291
[TBL] [Abstract][Full Text] [Related]
2. Asparaginase and MOPP treatment of dogs with lymphoma.
Brodsky EM; Maudlin GN; Lachowicz JL; Post GS
J Vet Intern Med; 2009; 23(3):578-84. PubMed ID: 19645842
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
[TBL] [Abstract][Full Text] [Related]
4. Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs.
Rassnick KM; Bailey DB; Malone EK; Intile JL; Kiselow MA; Flory AB; Barlow LL; Balkman CE; Barnard SM; Waite AH
Vet Comp Oncol; 2010 Dec; 8(4):243-53. PubMed ID: 21062406
[TBL] [Abstract][Full Text] [Related]
5. Advances in chemotherapy for large cell lymphoma.
Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.
Zimmerman K; Walsh KA; Ferrari JT; Keuler NS; Atherton MJ; Lenz JA
Vet Comp Oncol; 2023 Sep; 21(3):503-508. PubMed ID: 37222086
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).
Fahey CE; Milner RJ; Barabas K; Lurie D; Kow K; Parfitt S; Lyles S; Clemente M
J Am Vet Med Assoc; 2011 Jul; 239(2):209-15. PubMed ID: 21756176
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
[TBL] [Abstract][Full Text] [Related]
9. MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000).
Rassnick KM; Mauldin GE; Al-Sarraf R; Mauldin GN; Moore AS; Mooney SC
J Vet Intern Med; 2002; 16(5):576-80. PubMed ID: 12322709
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
[TBL] [Abstract][Full Text] [Related]
11. Treatment of feline intermediate to high-grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017-2021).
Moore AS; Frimberger AE
Vet Comp Oncol; 2024 Mar; 22(1):106-114. PubMed ID: 38152842
[TBL] [Abstract][Full Text] [Related]
12. Comparison of COAP and UW-19 protocols for dogs with multicentric lymphoma.
Hosoya K; Kisseberth WC; Lord LK; Alvarez FJ; Lara-Garcia A; Kosarek CE; London CA; Couto CG
J Vet Intern Med; 2007; 21(6):1355-63. PubMed ID: 18196747
[TBL] [Abstract][Full Text] [Related]
13. Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.
Wang SL; Lee JJ; Liao AT
Can Vet J; 2016 Mar; 57(3):271-6. PubMed ID: 26933263
[TBL] [Abstract][Full Text] [Related]
14. New treatment options have changed the survival of patients with follicular lymphoma.
Fisher RI; LeBlanc M; Press OW; Maloney DG; Unger JM; Miller TP
J Clin Oncol; 2005 Nov; 23(33):8447-52. PubMed ID: 16230674
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma.
Myers NC; Moore AS; Rand WM; Gliatto J; Cotter SM
J Vet Intern Med; 1997; 11(6):333-9. PubMed ID: 9470157
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma.
Rassnick KM; McEntee MC; Erb HN; Burke BP; Balkman CE; Flory AB; Kiselow MA; Autio K; Gieger TL
J Vet Intern Med; 2007; 21(6):1364-73. PubMed ID: 18196748
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of neutrophilia as a prognostic factor in dogs with multicentric lymphoma treated with a cyclophosphamide, doxorubicin, vincristine, and prednisone-based chemotherapy protocol.
Veluvolu S; Pellin M; Vos N
J Am Vet Med Assoc; 2021 Sep; 259(5):494-502. PubMed ID: 34388019
[TBL] [Abstract][Full Text] [Related]
18. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma.
Saba CF; Thamm DH; Vail DM
J Vet Intern Med; 2007; 21(1):127-32. PubMed ID: 17338160
[TBL] [Abstract][Full Text] [Related]
20. Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.
Chen YC; Ho CL; Kao WY; Hwang JM; Sheu LF; Chao TY
Ann Hematol; 2001 Nov; 80(11):647-52. PubMed ID: 11757723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
